BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/9/2021 10:25:22 AM | Browse: 550 | Download: 788
 |
Received |
|
2021-01-28 04:34 |
|
Peer-Review Started |
|
2021-01-28 04:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2021-03-30 02:46 |
|
Revised |
|
2021-04-12 06:25 |
|
Second Decision |
|
2021-07-05 05:52 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2021-07-06 08:56 |
|
Articles in Press |
|
2021-07-06 08:56 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2021-07-19 21:50 |
|
Typeset the Manuscript |
|
2021-08-04 08:10 |
|
Publish the Manuscript Online |
|
2021-08-09 10:25 |
| ISSN |
1948-9358 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Endocrinology & Metabolism |
| Manuscript Type |
Systematic Reviews |
| Article Title |
What can we learn from β-cell-failure biomarkers applications into diabetes in childhood? A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
María F Calderón-Hernández, Nelly F Altamirano-Bustamante, Cristina Revilla-Monsalve, María Belen Mosquera-Andrade and Myriam M Altamirano-Bustamante |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Mexico’s National Council of Science and Technology (CONACYT) |
SALUD-2010-C02-151942 |
| Institute of Science and Technology of Mexico City |
|
|
| Corresponding Author |
Myriam M Altamirano-Bustamante, MD, PhD, Academic Research, Research Scientist, Senior Scientist, Teacher, Unidad de Investigación en Enfermedades Metabólicas, Centro Médico Nacional Siglo XXI, IMSS, Avenida Cuauhtémoc 330, Mexico 06720, Mexico. myriamab@unam.mx |
| Key Words |
Biomarker; β cell failure; Children; Adolescents; Diabetes mellitus; Metabolic syndrome |
| Core Tip |
β cell failure biomarkers is until now an elusive task, the searching of a molecule that work as a biomarker and therapeutic target is a challenge. The data obtained in this study demonstrated that real human islet amyloid polypeptide amyloid oligomers could be used as a sensitive and specific marker for the diabetes as a protein conformational disease. |
| Publish Date |
2021-08-09 10:25 |
| Citation |
Calderón-Hernández MF, Altamirano-Bustamante NF, Revilla-Monsalve C, Mosquera-Andrade MB, Altamirano-Bustamante MM. What can we learn from β-cell-failure biomarkers applications into diabetes in childhood? A systematic review. World J Diabetes 2021; 12(8): 1325-1362 |
| URL |
https://www.wjgnet.com/1948-9358/full/v12/i8/1325.htm |
| DOI |
https://dx.doi.org/10.4239/wjd.v12.i8.1325 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
